Canada markets closed

Covalon Technologies Ltd. (COV.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
3.3600+0.0200 (+0.60%)
At close: 03:59PM EDT

Covalon Technologies Ltd.

1660 Tech Avenue
Unit 5
Mississauga, ON L4W 5S7
Canada
905 568 8400
https://www.covalon.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Amir Boloor CFAExecutive Chairman647.1kN/AN/A
Mr. Ronald HebertSenior Vice President of Growth474.77kN/AN/A
Mr. Brent AshtonCEO & DirectorN/AN/AN/A
Dr. Valerio DiTizioCo-Founder, Chief Scientific Officer & VP177kN/A1968
Ms. Katie MartinovichInterim Chief Financial OfficerN/AN/AN/A
Ms. Kim CrooksSenior Vice President of Operations172.76kN/AN/A
Mr. Greg LeszczynskiVice President of Human ResourcesN/AN/AN/A
Gerry ArambulaPresident of Covalon Technologies AG Ltd.634.76kN/AN/A
Mr. Hamed AbbasianVice President of Business Development412.99kN/AN/A
Emily HillExecutive Assistant to the CEON/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

Corporate Governance

Covalon Technologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.